Cargando…

Increased integrated testing for HIV, hepatitis C and sexually transmitted infections in health care facilities: results from the INTEGRATE Joint Action pilots in Lithuania, Romania and Spain

BACKGROUND: Indicator condition guided HIV testing is a proven effective strategy for increasing HIV diagnosis in health care facilities. As part of the INTEGRATE Joint Action, we conducted four pilot studies, aiming to increase integrated testing for HIV/HCV/HBV and sexually transmitted infections,...

Descripción completa

Detalles Bibliográficos
Autores principales: Matulionytė, R., Jakobsen, M. L., Grecu, V. I., Grigaitiene, J., Raudonis, T., Stoniene, L., Olteanu, M., de la Mora, L., Raben, D., Sullivan, A. K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438813/
https://www.ncbi.nlm.nih.gov/pubmed/34517830
http://dx.doi.org/10.1186/s12879-021-06537-2
_version_ 1783752417805860864
author Matulionytė, R.
Jakobsen, M. L.
Grecu, V. I.
Grigaitiene, J.
Raudonis, T.
Stoniene, L.
Olteanu, M.
de la Mora, L.
Raben, D.
Sullivan, A. K.
author_facet Matulionytė, R.
Jakobsen, M. L.
Grecu, V. I.
Grigaitiene, J.
Raudonis, T.
Stoniene, L.
Olteanu, M.
de la Mora, L.
Raben, D.
Sullivan, A. K.
author_sort Matulionytė, R.
collection PubMed
description BACKGROUND: Indicator condition guided HIV testing is a proven effective strategy for increasing HIV diagnosis in health care facilities. As part of the INTEGRATE Joint Action, we conducted four pilot studies, aiming to increase integrated testing for HIV/HCV/HBV and sexually transmitted infections, by introducing and expanding existing indicator condition guided HIV testing methods. METHODS: Pilot interventions included combined HIV/HCV testing in a dermatovenerology clinic and a clinic for addictive disorders in Lithuania; Increasing HIV testing rates in a tuberculosis clinic in Romania by introducing a patient information leaflet and offering testing for HIV/HCV/sexually transmitted infections to chemsex-users in Barcelona. Methods for implementing indicator condition guided HIV testing were adapted to include integrated testing. Testing data were collected retrospectively and prospectively. Staff were trained in all settings, Plan-do-study-act cycles frequently performed and barriers to implementation reported. RESULTS: In established indicator conditions, HIV absolute testing rates increased from 10.6 to 71% in the dermatovenerology clinic over an 18 months period. HIV testing rates improved from 67.4% at baseline to 94% in the tuberculosis clinic. HCV testing was added to all individuals in the dermatovenerology clinic, eight patients of 1701 tested positive (0.47%). HBV testing was added to individuals with sexually transmitted infections with a 0.44% positivity rate (2/452 tested positive). The Indicator condition guided HIV testing strategy was expanded to offer HIV/HCV testing to people with alcohol dependency and chemsex-users. 52% of chemsex-users tested positive for ≥ 1 sexually transmitted infection and among people with alcohol dependency 0.3 and 3.7% tested positive for HIV and HCV respectively. CONCLUSIONS: The four pilot studies successfully increased integrated testing in health care settings, by introducing testing for HBV/HCV and sexually transmitted infections along with HIV testing for established indicator conditions and expanding the strategy to include new indicators; alcohol dependency and chemsex. HCV testing of individuals with alcohol abuse showed high positivity rates and calls for further implementation studies. Methods used for implementing indicator condition guided HIV Testing have proven transferable to implementation of integrated testing. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-021-06537-2.
format Online
Article
Text
id pubmed-8438813
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-84388132021-09-14 Increased integrated testing for HIV, hepatitis C and sexually transmitted infections in health care facilities: results from the INTEGRATE Joint Action pilots in Lithuania, Romania and Spain Matulionytė, R. Jakobsen, M. L. Grecu, V. I. Grigaitiene, J. Raudonis, T. Stoniene, L. Olteanu, M. de la Mora, L. Raben, D. Sullivan, A. K. BMC Infect Dis Research BACKGROUND: Indicator condition guided HIV testing is a proven effective strategy for increasing HIV diagnosis in health care facilities. As part of the INTEGRATE Joint Action, we conducted four pilot studies, aiming to increase integrated testing for HIV/HCV/HBV and sexually transmitted infections, by introducing and expanding existing indicator condition guided HIV testing methods. METHODS: Pilot interventions included combined HIV/HCV testing in a dermatovenerology clinic and a clinic for addictive disorders in Lithuania; Increasing HIV testing rates in a tuberculosis clinic in Romania by introducing a patient information leaflet and offering testing for HIV/HCV/sexually transmitted infections to chemsex-users in Barcelona. Methods for implementing indicator condition guided HIV testing were adapted to include integrated testing. Testing data were collected retrospectively and prospectively. Staff were trained in all settings, Plan-do-study-act cycles frequently performed and barriers to implementation reported. RESULTS: In established indicator conditions, HIV absolute testing rates increased from 10.6 to 71% in the dermatovenerology clinic over an 18 months period. HIV testing rates improved from 67.4% at baseline to 94% in the tuberculosis clinic. HCV testing was added to all individuals in the dermatovenerology clinic, eight patients of 1701 tested positive (0.47%). HBV testing was added to individuals with sexually transmitted infections with a 0.44% positivity rate (2/452 tested positive). The Indicator condition guided HIV testing strategy was expanded to offer HIV/HCV testing to people with alcohol dependency and chemsex-users. 52% of chemsex-users tested positive for ≥ 1 sexually transmitted infection and among people with alcohol dependency 0.3 and 3.7% tested positive for HIV and HCV respectively. CONCLUSIONS: The four pilot studies successfully increased integrated testing in health care settings, by introducing testing for HBV/HCV and sexually transmitted infections along with HIV testing for established indicator conditions and expanding the strategy to include new indicators; alcohol dependency and chemsex. HCV testing of individuals with alcohol abuse showed high positivity rates and calls for further implementation studies. Methods used for implementing indicator condition guided HIV Testing have proven transferable to implementation of integrated testing. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-021-06537-2. BioMed Central 2021-09-13 /pmc/articles/PMC8438813/ /pubmed/34517830 http://dx.doi.org/10.1186/s12879-021-06537-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Matulionytė, R.
Jakobsen, M. L.
Grecu, V. I.
Grigaitiene, J.
Raudonis, T.
Stoniene, L.
Olteanu, M.
de la Mora, L.
Raben, D.
Sullivan, A. K.
Increased integrated testing for HIV, hepatitis C and sexually transmitted infections in health care facilities: results from the INTEGRATE Joint Action pilots in Lithuania, Romania and Spain
title Increased integrated testing for HIV, hepatitis C and sexually transmitted infections in health care facilities: results from the INTEGRATE Joint Action pilots in Lithuania, Romania and Spain
title_full Increased integrated testing for HIV, hepatitis C and sexually transmitted infections in health care facilities: results from the INTEGRATE Joint Action pilots in Lithuania, Romania and Spain
title_fullStr Increased integrated testing for HIV, hepatitis C and sexually transmitted infections in health care facilities: results from the INTEGRATE Joint Action pilots in Lithuania, Romania and Spain
title_full_unstemmed Increased integrated testing for HIV, hepatitis C and sexually transmitted infections in health care facilities: results from the INTEGRATE Joint Action pilots in Lithuania, Romania and Spain
title_short Increased integrated testing for HIV, hepatitis C and sexually transmitted infections in health care facilities: results from the INTEGRATE Joint Action pilots in Lithuania, Romania and Spain
title_sort increased integrated testing for hiv, hepatitis c and sexually transmitted infections in health care facilities: results from the integrate joint action pilots in lithuania, romania and spain
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438813/
https://www.ncbi.nlm.nih.gov/pubmed/34517830
http://dx.doi.org/10.1186/s12879-021-06537-2
work_keys_str_mv AT matulionyter increasedintegratedtestingforhivhepatitiscandsexuallytransmittedinfectionsinhealthcarefacilitiesresultsfromtheintegratejointactionpilotsinlithuaniaromaniaandspain
AT jakobsenml increasedintegratedtestingforhivhepatitiscandsexuallytransmittedinfectionsinhealthcarefacilitiesresultsfromtheintegratejointactionpilotsinlithuaniaromaniaandspain
AT grecuvi increasedintegratedtestingforhivhepatitiscandsexuallytransmittedinfectionsinhealthcarefacilitiesresultsfromtheintegratejointactionpilotsinlithuaniaromaniaandspain
AT grigaitienej increasedintegratedtestingforhivhepatitiscandsexuallytransmittedinfectionsinhealthcarefacilitiesresultsfromtheintegratejointactionpilotsinlithuaniaromaniaandspain
AT raudonist increasedintegratedtestingforhivhepatitiscandsexuallytransmittedinfectionsinhealthcarefacilitiesresultsfromtheintegratejointactionpilotsinlithuaniaromaniaandspain
AT stonienel increasedintegratedtestingforhivhepatitiscandsexuallytransmittedinfectionsinhealthcarefacilitiesresultsfromtheintegratejointactionpilotsinlithuaniaromaniaandspain
AT olteanum increasedintegratedtestingforhivhepatitiscandsexuallytransmittedinfectionsinhealthcarefacilitiesresultsfromtheintegratejointactionpilotsinlithuaniaromaniaandspain
AT delamoral increasedintegratedtestingforhivhepatitiscandsexuallytransmittedinfectionsinhealthcarefacilitiesresultsfromtheintegratejointactionpilotsinlithuaniaromaniaandspain
AT rabend increasedintegratedtestingforhivhepatitiscandsexuallytransmittedinfectionsinhealthcarefacilitiesresultsfromtheintegratejointactionpilotsinlithuaniaromaniaandspain
AT sullivanak increasedintegratedtestingforhivhepatitiscandsexuallytransmittedinfectionsinhealthcarefacilitiesresultsfromtheintegratejointactionpilotsinlithuaniaromaniaandspain